Clinical meaning
Cancer pain is a complex, multidimensional experience that affects 55-70% of patients undergoing active treatment and up to 90% of patients with advanced disease. Pain in cancer arises through several distinct pathophysiological mechanisms that often coexist in the same patient. Nociceptive pain results from activation of peripheral pain receptors (nociceptors) by tissue damage and can be somatic (arising from bone, muscle, skin, and connective tissue -- described as aching, throbbing, or pressure-like) or visceral (arising from internal organs -- described as deep, cramping, squeezing, or referred to distant sites). Neuropathic pain results from direct injury to peripheral or central nervous system structures by tumor invasion or compression of nerves, nerve plexuses, or the spinal cord; it is described as burning, shooting, tingling, or electric-shock-like sensations and often responds poorly to standard analgesics alone. Bone pain is the most common type of cancer pain, occurring when tumor cells metastasize to bone and activate osteoclast-mediated bone resorption through the RANK-RANKL pathway. The tumor microenvironment releases inflammatory mediators (prostaglandins, cytokines including TNF-alpha and interleukins, nerve growth factor) that sensitize peripheral nociceptors, lowering their...